Please login to the form below

Not currently logged in


This page shows the latest Merck news and features for those working in and with pharma, biotech and healthcare.

A look ahead to key trial readouts at ESMO

A look ahead to key trial readouts at ESMO

In immuno-oncology, this year’s offering includes a first showing for data in first-line advanced renal cell carcinoma for Merck KGaA/Pfizer’s Bavencio (avelumab) in the JAVELIN Renal ... Merck &Co/MSD – already dominating non-small cell lung

Latest news

More from news
Approximately 359 fully matching, plus 1,079 partially matching documents found.

Latest Intelligence

  • Chinese biotech’s global ambitions Chinese biotech’s global ambitions

    The company has a PD-1 cancer immunotherapy, tislelizumab, in development in China, and believes it can compete in the market alongside multinationals MSD (Merck in the US) and BMS and

  • The European Medicines Agency: PRIME’d for access? The European Medicines Agency: PRIME’d for access?

    sales, and 6 are in the top 10 companies with Pfizer (with Spark Therapeutics), Novartis (by acquiring AveXis), Celgene (with Bluebird and through acquiring Juno Therapeutics), Sanofi, Roche and Merck all

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    Checkpoint inhibitors – old and new. The first wave of checkpoint inhibitors targeting PD-(L) 1 and CTLA-4, from Bristol-Myers Squibb, Merck &Co, Roche, AstraZeneca and Merck KGaA/Pfizer, have ... Last year, the FDA approved Merck’s Keytruda

  • Advancing women in healthcare Advancing women in healthcare

    Taking on the mantle of HBA’s Woman of the Year 2018 is Julie Gerberding, Merck &Co’s chief patient officer, and head of global public policy and population health. ... She joined Merck &Co in 2009 and sees her role in promoting vaccines and

  • 30 Women Leaders in UK Healthcare

    2. Louise Houson, MSD UK and Ireland General Manager. L ouise Houson is the first ever woman leader of MSD in the UK and Ireland (known as Merck Inc in North

More from intelligence
Approximately 7 fully matching, plus 115 partially matching documents found.

Latest appointments

More from appointments
Approximately 38 fully matching, plus 135 partially matching documents found.

Latest from PMHub

  • Marketing strategy in complex environments

    Marketing strategy in complex environments. Age-old treatment protocols are being replaced with new and innovative treatment paradigms that will revolutionise the healthcare industry for years to come. Kulveer Singh and Mark Assenti talk through

  • Personalizing customer engagement in pharma

    Personalizing customer engagement in pharma. Barcelona eyeforpharma 2015 highlights: Philippe Kirby, Merck, David Hunt, Havas LYNX, and Richie Bavasso, Agnitio share their views on digital pharma trends. ... Summary/transcript. Barcelona eyeforpharma

  • Novartis CEO on patient value

    Including:. · How GSK, Pfizer and Merck are feeding patient voice, customer insight and point of value into their service strategies for user uplift. · ... You can see the full brochure which drills down in to each session here: . With attendees from

  • Active Life Ahead: Brand Campaign

    Client: Merck Sharp &Dohme.

  • Active Life Ahead: Press Advert

    Client: Merck Sharp &Dohme.

More from PMHub
Approximately 1 fully matching, plus 38 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...